1.46
-0.04(-2.67%)
Currency In USD
| Previous Close | 1.5 |
| Open | 1.46 |
| Day High | 1.51 |
| Day Low | 1.44 |
| 52-Week High | 2.55 |
| 52-Week Low | 1.19 |
| Volume | 12,663 |
| Average Volume | 151,550 |
| Market Cap | 11.65M |
| PE | -1.16 |
| EPS | -1.26 |
| Moving Average 50 Days | 1.56 |
| Moving Average 200 Days | 1.71 |
| Change | -0.04 |
If you invested $1000 in BioRestorative Therapies, Inc. (BRTX) 10 years ago, it would be worth $0.08 as of November 05, 2025 at a share price of $1.46. Whereas If you bought $1000 worth of BioRestorative Therapies, Inc. (BRTX) shares 5 years ago, it would be worth $14.04 as of November 05, 2025 at a share price of $1.46.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
BioRestorative Awarded Notice of Allowance for Japanese Patent – Expands Protection for Potential Cell-Based Alternative to Multi-Billion Dollar GLP-1 Drug Market
GlobeNewswire Inc.
Oct 27, 2025 11:30 AM GMT
MELVILLE, N.Y., Oct. 27, 2025 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ:BRTX), a regenerative medicine innovator focused on stem cell-based therapies and products, today announced a major
BioRestorative Strengthens Commercial Leadership with Appointment of Crystal Romano as Head of Global Commercial Operations to Accelerate Growth of Cell-Based Product Portfolio
GlobeNewswire Inc.
Oct 22, 2025 1:35 PM GMT
MELVILLE, N.Y., Oct. 22, 2025 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ:BRTX), a regenerative medicine innovator focused on stem cell-based therapies and products, today announced that Cr
BioRestorative Therapies to Participate in the 2025 Maxim Growth Summit
GlobeNewswire Inc.
Oct 15, 2025 1:35 PM GMT
MELVILLE, N.Y., Oct. 15, 2025 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ:BRTX), a regenerative medicine innovator focused on stem cell-based therapies and products, is pleased to announce